Trusted Resources: Education
Scientific literature and patient education texts
Macular Changes in a Mucopolysaccharidosis Type I Patient With Earlier Systemic Therapies
source: Case Reports in Ophthalmological Medicine
year: 2021
authors: Magalhães A,Cunha AM,Vilares-Morgado R,Leão-Teles E,Rodrigues E,Falcão M,Carneiro Â,Breda J,Falcão-Reis F
summary/abstract:To describe retinal findings in a patient with mucopolysaccharidosis type I (MPS I) that underwent an early treatment with hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT). . We describe a case of a 12-year-old female with a biochemical and genetic diagnosis of MPS I. She underwent HSCT and ERT on the first year of life. The visual acuity was 5/10 in both eyes and she had bilateral grade 2 corneal haze. Spectral domain optical coherence tomography (SD-OCT) revealed thickening of the external limiting membrane (ELM) at the fovea. In the parafoveal and perifoveal regions, SD-OCT displayed a loss of the interdigitation, ellipsoid, and myoid zones and of the ELM accompanied by progressive thinning of the outer nuclear layer. Fundus infrared imaging revealed a hyperreflective ring centred on the fovea and hyporeflective areas in temporal parafoveal regions in both eyes. OCT imaging revealed two hyperreflective rings on the outer retinal level.
organization: Department of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, Portugal.DOI: 10.1155/2021/8866837
read more
Related Content
-
Facial and Cephalometric Features of Individuals With Mucopolysaccharidosis: A Cross-Sectional StudyThe aim was to assess craniofacial featu...
-
Hurler Syndrome Treatment Market Research Prophesied to Grow at a Faster Pace By 2026This Hurler Syndrome Treatment market re...
-
Stewart RustDr Rust completed his first degree at Le...
-
Experimental MPS 1 Therapy Shows Biomarker Activity, Improved FunctionREGENXBIO presented results from its ong...
-
The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-A...Nonrandomized studies are usually exclud...
-
Paul Orchard, MDDr. Paul Orchard is the Medical Director...
-
Mucopolysaccharidosis Type I Diagnosed by Aortic and Mitral Valve ReplacementA 32-year-old developmentally delayed ma...